vs
Burford Capital Ltd(BUR)与ROCKWELL MEDICAL, INC.(RMTI)财务数据对比。点击上方公司名可切换其他公司
Burford Capital Ltd的季度营收约是ROCKWELL MEDICAL, INC.的1.8倍($33.4M vs $18.3M),ROCKWELL MEDICAL, INC.净利率更高(-3.0% vs -112.2%,领先109.2%),ROCKWELL MEDICAL, INC.自由现金流更多($2.2M vs $-29.3M)
伯福德资本成立于2009年,是一家面向法律市场的专业金融服务提供商,总部位于根西岛,业务覆盖全球。该公司为企业法务部门、律师事务所的诉讼、仲裁、资产追回等相关法律活动提供资金支持,同时也提供配套的法律金融咨询服务。
罗克韦尔医疗成立于1996年,总部位于美国密歇根州威克瑟姆,是一家上市制药企业,核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。
BUR vs RMTI — 直观对比
营收规模更大
BUR
是对方的1.8倍
$18.3M
净利率更高
RMTI
高出109.2%
-112.2%
自由现金流更多
RMTI
多$31.5M
$-29.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $33.4M | $18.3M |
| 净利润 | $-37.5M | $-554.0K |
| 毛利率 | — | 21.1% |
| 营业利润率 | -37.9% | -2.2% |
| 净利率 | -112.2% | -3.0% |
| 营收同比 | — | -25.6% |
| 净利润同比 | — | 26.7% |
| 每股收益(稀释后) | $-0.16 | $-0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BUR
RMTI
| Q4 25 | $33.4M | $18.3M | ||
| Q3 25 | $69.8M | $15.9M | ||
| Q2 25 | $191.3M | $16.1M | ||
| Q1 25 | $118.9M | $18.9M | ||
| Q4 24 | — | $24.7M | ||
| Q3 24 | $159.7M | $28.3M | ||
| Q2 24 | $44.3M | $25.8M | ||
| Q1 24 | — | $22.7M |
净利润
BUR
RMTI
| Q4 25 | $-37.5M | $-554.0K | ||
| Q3 25 | $-19.2M | $-1.8M | ||
| Q2 25 | $88.3M | $-1.5M | ||
| Q1 25 | $30.9M | $-1.5M | ||
| Q4 24 | — | $-756.0K | ||
| Q3 24 | $53.7M | $1.7M | ||
| Q2 24 | $-29.9M | $343.0K | ||
| Q1 24 | — | $-1.7M |
毛利率
BUR
RMTI
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
营业利润率
BUR
RMTI
| Q4 25 | -37.9% | -2.2% | ||
| Q3 25 | 35.5% | -9.9% | ||
| Q2 25 | 74.3% | -8.4% | ||
| Q1 25 | 65.4% | -7.2% | ||
| Q4 24 | — | -2.1% | ||
| Q3 24 | 76.1% | 6.8% | ||
| Q2 24 | 32.0% | 2.0% | ||
| Q1 24 | — | -5.8% |
净利率
BUR
RMTI
| Q4 25 | -112.2% | -3.0% | ||
| Q3 25 | -27.4% | -11.0% | ||
| Q2 25 | 46.2% | -9.3% | ||
| Q1 25 | 26.0% | -8.0% | ||
| Q4 24 | — | -3.1% | ||
| Q3 24 | 33.7% | 5.9% | ||
| Q2 24 | -67.6% | 1.3% | ||
| Q1 24 | — | -7.6% |
每股收益(稀释后)
BUR
RMTI
| Q4 25 | $-0.16 | $-0.01 | ||
| Q3 25 | $-0.09 | $-0.05 | ||
| Q2 25 | $0.39 | $-0.05 | ||
| Q1 25 | $0.14 | $-0.04 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | $0.24 | $0.04 | ||
| Q2 24 | $-0.14 | $0.01 | ||
| Q1 24 | — | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $943.5M | $10.7M |
| 总债务越低越好 | $2.1B | — |
| 股东权益账面价值 | $2.4B | $37.0M |
| 总资产 | $6.6B | $57.1M |
| 负债/权益比越低杠杆越低 | 0.87× | — |
8季度趋势,按日历期对齐
现金及短期投资
BUR
RMTI
| Q4 25 | $943.5M | $10.7M | ||
| Q3 25 | $677.7M | $13.6M | ||
| Q2 25 | $372.2M | $12.5M | ||
| Q1 25 | $486.6M | $11.4M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M | ||
| Q1 24 | — | $6.6M |
总债务
BUR
RMTI
| Q4 25 | $2.1B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
BUR
RMTI
| Q4 25 | $2.4B | $37.0M | ||
| Q3 25 | $2.5B | $37.0M | ||
| Q2 25 | $2.5B | $30.4M | ||
| Q1 25 | $2.4B | $31.5M | ||
| Q4 24 | — | $32.6M | ||
| Q3 24 | $3.2B | $29.1M | ||
| Q2 24 | $3.1B | $23.5M | ||
| Q1 24 | — | $20.6M |
总资产
BUR
RMTI
| Q4 25 | $6.6B | $57.1M | ||
| Q3 25 | $6.7B | $57.5M | ||
| Q2 25 | $6.3B | $52.6M | ||
| Q1 25 | $6.2B | $54.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $57.1M | ||
| Q2 24 | — | $53.0M | ||
| Q1 24 | — | $50.7M |
负债/权益比
BUR
RMTI
| Q4 25 | 0.87× | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.71× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-29.0M | $2.3M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $2.2M |
| 自由现金流率自由现金流/营收 | -87.7% | 12.0% |
| 资本支出强度资本支出/营收 | 0.8% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $21.4M | $-1.2M |
8季度趋势,按日历期对齐
经营现金流
BUR
RMTI
| Q4 25 | $-29.0M | $2.3M | ||
| Q3 25 | $-20.1M | $-1.3M | ||
| Q2 25 | $-84.2M | $1.8M | ||
| Q1 25 | $155.2M | $-3.5M | ||
| Q4 24 | — | $865.0K | ||
| Q3 24 | $-97.4M | $4.3M | ||
| Q2 24 | $53.0M | $1.4M | ||
| Q1 24 | — | $-2.4M |
自由现金流
BUR
RMTI
| Q4 25 | $-29.3M | $2.2M | ||
| Q3 25 | $-20.1M | $-1.5M | ||
| Q2 25 | $-84.3M | $1.7M | ||
| Q1 25 | $155.1M | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | $-97.4M | $4.1M | ||
| Q2 24 | $52.9M | $1.2M | ||
| Q1 24 | — | $-2.5M |
自由现金流率
BUR
RMTI
| Q4 25 | -87.7% | 12.0% | ||
| Q3 25 | -28.8% | -9.6% | ||
| Q2 25 | -44.1% | 10.5% | ||
| Q1 25 | 130.5% | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | -61.0% | 14.4% | ||
| Q2 24 | 119.5% | 4.5% | ||
| Q1 24 | — | -11.1% |
资本支出强度
BUR
RMTI
| Q4 25 | 0.8% | 0.5% | ||
| Q3 25 | 0.1% | 1.4% | ||
| Q2 25 | 0.1% | 1.0% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | — | 0.6% |
现金转化率
BUR
RMTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.95× | — | ||
| Q1 25 | 5.02× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.81× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BUR
| Principal Finance Segment | $29.1M | 87% |
| Other | $3.5M | 10% |
| Management Fee Income | $878.0K | 3% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |